English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Wynca subsidiary’s annual 6,000-ton glufosinate project expected to enter trial production by year’s endqrcode

Jul. 21, 2021

Favorites Print
Forward
Jul. 21, 2021

2021-02.png

Make Virtual Participation to follow up the supply dynamics and make right procurement strategy! 


Recently, on an investment platform of China, Wynca was asked about its glufosinate capacity.


The company replied that its subsidiary, Wynca Ningxia, is implementing an annual 6,000-ton glufosinate project, which includes intermediate diethyl ester. Phase I of the project, covering 3,000 tons glufosinate inclusive of diethyl annually, is expected to enter trial production by the end of 2021.


QQ截图20210303155608.pngQQ截图20210303155617.png


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox